Rewards
All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
Trending on Bing
NBA Hall of Famer dies
‘Whites only’ job posting fine
Tim Allen pay gap ended show
Shark sighting closes beach
Inmates break out of jail
Defends wife against trolls
Slammed for remarks
Rafah attack 'tragic mistake'
Son underwent heart surgery
On Democratic criticism
Chicago man sues city, police
Accused of sexual assault
Teen survives 400-foot fall
Retiring after 3 decades
Plane catches fire at O'Hare
Join ‘Knives Out 3′ cast
Attacks judges in post
AI won't 'take your job'
Wins Larry Bird Trophy
'Champion in recess'
$4.2M payout sets record
'Doing great' after falling ill
Celtics reach NBA Finals
US storms kill 22
To be named Kraken coach?
Closing arguments Tuesday
Honors fallen US troops
Reiterates support for ISR
Venus volcanically active
CrowdTangle safety features
Iran uranium stockpile grows
Baseball tournament bracket
'Furiosa' claims No. 1 spot
To invest in Italy cloud plan?
Oil price surges
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Johnson & Johnson, Kenvue
J&J to exit spinoff Kenvue with latest stake sale
(Reuters) -Tylenol maker Kenvue said on Monday that Johnson & Johnson will sell its remaining 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business.
J&J to Sell Remaining Stake in Kenvue Spinoff
By Dean Seal Johnson & Johnson plans to unload its remaining 9.5% stake in Kenvue in a public offering set about a year after it started splitting
Johnson & Johnson Is Officially Getting Out of Kenvue (KVUE) Stock
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Kenvue (NYSE:KVUE) stock is in the news Monday after the company
J&J to exit Kenvue, a year after spinoff
Tylenol maker Kenvue said on Monday that Johnson & Johnson will offload its entire 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business.
Johnson & Johnson is selling its remaining Kenvue shares
Johnson & Johnson is selling its remaining shares in Kenvue Inc., the consumer-health business that it spun out last year.
Johnson & Johnson Will Sell Remaining Stake in Kenvue (NYSE:KVUE)
Kenvue (NYSE:KVUE) announced on Monday that Johnson & Johnson (NYSE:JNJ) will sell its remaining 9.5% stake in the consumer health company. This
Johnson & Johnson To Sell Entire Stake In Spin-Off Kenvue
Healthcare giant Johnson & Johnson (JNJ) plans to sell its entire stake in spun-off company Kenvue (KVUE). Johnson & Johnson currently holds 182.3 million shares in Kenvue stock. The company plans to sell the shares it owns in a debt-for-equity exchange.
FiercePharma
10d
UPDATED: GSK raises £1.25B through final Haleon share sale
Right on the heels of a similar move by Johnson & Johnson, GSK is offloading the rest of its stake in the consumer healthcare ...
KELO
16d
Sioux Falls drug dealer gets 20 year sentence
SIOUX FALLS, S.D. (KELO.com) — A Sioux Falls drug dealer will be off the streets for a long time. Jason Winckler, 44, was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results